Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers.
52W Range
88thpctl
Volume
0.93×avg
Market Cap
564.08MUSD
P/E Ratio
1485.5TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Delcath Systems, Inc.
DCTHNASDAQ Capital Market·USD·Closed
Delcath Systems, Inc.
DCTHNASDAQ·USD·Closed
$16.34
−0.31%
$16.34
−$0.05 (0.31%)
52W Range
88thpctl
Volume
0.93×avg
Mkt Cap
564.08MUSD
P/E
1485.5TTM
Div Yield
–ann
DCTH: Delcath Systems, Inc. Stock Analysis | finqOS
